Darvon-n side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Darvon-n. Common side effects include drug hypersensitivity among females and arthralgia among males.

The phase IV clinical study is created by eHealthMe based on 77 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 13, 2022

77 people who take Darvon-N and have side effects are studied.


What is Darvon-N?

Darvon-n has active ingredients of propoxyphene napsylate. It is often used in pain. eHealthMe is studying from 86 Darvon-n users for its effectiveness, alternative drugs and more.

Number of Darvon-n reports submitted per year:

Darvon-n side effects.

Darvon-N side effects by time on the drug*:

< 1 month:

  1. Confusional state

1 - 6 months:

n/a

6 - 12 months:

  1. Loss of consciousness

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

  1. Drug toxicity

not specified:

  1. Overdose
  2. Squamous cell carcinoma (a cancer of a kind of epithelial cell)
  3. Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
  4. Weight increased
  5. Acute myocardial infarction (acute heart attack)
  6. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  7. Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
  8. Back disorder
  9. Binge eating (pattern of disordered eating which consists of episodes of uncontrollable eating)
  10. Blood albumin decreased

Darvon-N side effects by gender *:

female:

  1. Drug hypersensitivity
  2. Abdominal adhesions (inflammation of abdomen)
  3. Encephalopathy (functioning of the brain is affected by some agent or condition)
  4. Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
  5. Osteomyelitis (infection of bone)
  6. Weight increased
  7. Acute myocardial infarction (acute heart attack)
  8. Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
  9. Back disorder
  10. Binge eating (pattern of disordered eating which consists of episodes of uncontrollable eating)

male:

  1. Arthralgia (joint pain)
  2. Drug hypersensitivity
  3. Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
  4. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  5. Type 2 diabetes mellitus
  6. Drug ineffective
  7. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  8. Death
  9. Dizziness
  10. Drug toxicity

Darvon-N side effects by age (0-1 to 60+) *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Cholecystitis chronic (long lasting infection of gallbladder)
  2. Overdose

20-29:

n/a

30-39:

  1. Drug toxicity
  2. Weight increased

40-49:

  1. Abdominal adhesions (inflammation of abdomen)
  2. Confusional state
  3. Drug hypersensitivity
  4. Loss of consciousness
  5. Overdose

50-59:

  1. Drug hypersensitivity
  2. Osteomyelitis (infection of bone)
  3. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  4. Arthralgia (joint pain)
  5. Chest pain
  6. Death
  7. Drug ineffective
  8. Elbow deformity
  9. Pleural effusion (water on the lungs)
  10. Squamous cell carcinoma (a cancer of a kind of epithelial cell)

60+:

  1. Drug hypersensitivity
  2. Encephalopathy (functioning of the brain is affected by some agent or condition)
  3. Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
  4. Acute myocardial infarction (acute heart attack)
  5. Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
  6. Blood albumin decreased
  7. Drug ineffective
  8. Fibromyalgia (a long-term condition which causes pain all over the body)
  9. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  10. Pancreatic carcinoma (pancreatic cancer)

* Approximation only. Some reports may have incomplete information.

Do you take Darvon-n?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



How the study uses the data?

The study is based on propoxyphene napsylate (the active ingredients of Darvon-n) and Darvon-n (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Darvon-n:

All Darvon-n side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: